Using pre-clinical biomarkers and epidemiological models to assess the effects of cannabinoids on disease

The goal of this project funded by the National Center for Complementary and Integrative Health is to study the intriguing possibility that cannabis use might be protective against the development of obesity and type 2 diabetes mellitus, and to produce more definitive evidence from bench-to-bedside-to- community studies of cannabinoids and health outcomes, even if the cannabis-diabetes association turns out to be spurious. Here, we use pre-clinical rodent models of obesity and insulin resistance to study the metabolic health effects of cannabinoids.

decorative image